Lafond Kevin G 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 8, 2019
Insider Transaction Report
Form 4
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
- Award
Common Stock
2019-01-06+37,122→ 85,555 total - Award
Employee Stock Option (right to buy)
2019-01-06+58,536→ 58,536 totalExercise: $2.24Exp: 2029-01-06→ Common Stock (58,536 underlying)
Footnotes (2)
- [F1]12,374 shares shall vest on each of 12/31/2019, 12/31/2020 and 12/31/2021.
- [F2]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018.